Skip to content

Pediatrix Medical

US · MD #2735 by market cap Listed 1970
25.83 -0.17 -0.65%
Live - 5344 symbols - heartbeat 468s ago · 2026-10-07 19:54
After-hours 25.83 0.00%
Market cap
2.10B
P/B
2.38
EPS
1.94
Reader sentiment Are you bullish or bearish on MD?

Anonymous reader poll. Unscientific, not investment advice.

✦ Quant Ownership Signal how this is computed

Distributing
  • The number of reporting institutions decreased by 2 in the most recent period (2026/Q3).
  • Total institutional ownership fell 0.2 percentage points.

Institutional ownership

Held by institutions
106.75% -0.23pp
Institutions
359 -2
As of
2026/Q3 vs. prior period

Ownership vs. money flow

Aligned

Institutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.

Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.

Holder types

Mutual Fund93.44%
Hedge Fund6.24%
Public Company3.07%
Government Pension Fund2.56%
Individual/Insider1.63%
Private Company0.61%
Family Office/Trust0.34%
Bank/Investment Bank0.24%
Insurance Company0.11%

Top holders

BlackRock 17.29%
Vanguard Portfolio Management, LLC 7.55%
Dimensional Fund Advisors 5.32%
Vanguard Capital Management, LLC 5.24%
State Street Global Advisors 4.45%
Victory Capital Management Inc. 4.31%
Wasatch Advisors LP 3.15%
Geode Capital Management, LLC 2.81%
American Century Investment Management 2.76%
Fuller & Thaler Asset Management, Inc. 2.17%

Bar length is relative to the largest holder shown here, not to 100% of the company.

Insiders

50 filings tracked · 30 buys · 20 sells

NameRoleStake
Mark Ordan Chair 0.52%
Mary Ann Moore General Counsel 0.24%
D. Neeb Executive VP and Chief Investment & Strategy Officer 0.17%
Kasandra Rossi Senior Vice President of Financial Reporting & Assistant Treasurer 0.13%
Guy Sansone Lead Independent Director 0.11%
Thomas McEachin Independent Director 0.09%
John Starcher Independent Director 0.09%
Michael Rucker Independent Director 0.08%
Laura McDuffie -- 0.04%
Sylvia Young Independent Director 0.04%

Insider transactions most recent Form 4 filings

DateNameRoleTypeSharesPrice
2026-09-09 Laura McDuffie -- Sale to Issuer -6,000 $26.82
2026-08-13 Sylvia Young Independent Director Sale to Issuer -18,500 $26.62
2026-08-11 Guy Sansone Lead Independent Director Other Acquisition +472 $26.50
2026-08-11 Thomas McEachin Independent Director Other Acquisition +472 $26.50
2026-08-11 Sylvia Young Independent Director Other Acquisition +472 $26.50
2026-08-11 John Starcher Independent Director Other Acquisition +472 $26.50
2026-08-11 Shirley Weis Independent Director Other Acquisition +472 $26.50
2026-08-11 Kurt Newman Independent Director Other Acquisition +472 $26.50
2026-08-11 Laura McDuffie -- Other Acquisition +472 $26.50
2026-08-11 Michael Rucker Independent Director Other Acquisition +472 $26.50
2026-06-21 David Haddock -- Other Acquisition +20,036 --
2026-06-21 David Haddock -- Other Derivative Acquisition +51,000 --
2026-06-08 Mary Ann Moore General Counsel Other Acquisition +18,407 --
2026-06-08 Mary Ann Moore General Counsel Other Disposition -18,407 --
2026-06-01 Mark Ordan Chair Sale to Issuer -116,293 $21.54
2026-06-01 Mark Ordan Chair Other Acquisition +224,372 --
2026-05-31 D. Neeb Executive VP and Chief Investment & Strategy Officer Sale to Issuer -8,003 $21.54
2026-05-31 D. Neeb Executive VP and Chief Investment & Strategy Officer Other Acquisition +63,888 --
2026-05-31 Mary Ann Moore General Counsel Sale to Issuer -11,944 $21.54
2026-05-31 Kasandra Rossi Senior Vice President of Financial Reporting & Assistant Treasurer Sale to Issuer -3,701 $21.54

Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.